Literature DB >> 10851675

Salivary gland tumours treated in the stomatological clinics in Bratislava.

I Satko1, P Stanko, I Longauerová.   

Abstract

During the period of 1951-1996 a group of 1021 patients (484 men and 537 women, mean age 53 years, range 2-87 years) with salivary gland tumours were analysed retrospectively. The mean follow-up period was 8 years (range 10 months-25 years). The frequency of benign tumours was 74% (n = 755) and malignant tumours 26% (n = 266). Lesions were sited in the parotid gland 83% (n = 847), in the submandibular gland 10.8% (n = 110), in the sublingual gland 3.2% (n = 33) and in the minor salivary glands 3% (n = 31). The most common benign tumours were pleomorphic adenoma in 53.9% (n = 550) and Warthin's tumour 9.7% (n = 99). Of the malignancies, the adenoid cystic carcinoma was most common (6.4% of cases, n = 65) and mucoepidermoid carcinoma occurred in 5.2% (n = 53). The predominant therapy was surgery alone or in combination with postoperative radiotherapy in 93.7% (957 cases), radiotherapy alone after fine needle aspiration biopsy for 4.7%, and 19 patients remained untreated.

Entities:  

Mesh:

Year:  2000        PMID: 10851675     DOI: 10.1054/jcms.1999.0092

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  15 in total

Review 1.  Salivary gland tumor: a review of 599 cases in a Brazilian population.

Authors:  Flávia Aparecida de Oliveira; Eliza Carla Barroso Duarte; Cláudia Teixeira Taveira; Aline Abreu Máximo; Erica Carvalho de Aquino; Rita de Cássia Alencar; Eneida Franco Vencio
Journal:  Head Neck Pathol       Date:  2009-09-16

2.  Salivary gland tumors in Turkey: demographic features and histopathological distribution of 510 patients.

Authors:  Yusuf Kızıl; Utku Aydil; Ozgür Ekinci; Alper Dilci; Ahmet Köybaşıoğlu; Mehmet Düzlü; Erdoğan Inal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-11-10

3.  Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas.

Authors:  T Schneider; A Strehl; C Linz; R Brands; S Hartmann; F Beckford; A Rosenwald; A C Kübler; U D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2015-08-06       Impact factor: 3.573

4.  Tubular-trabecular type Basal cell adenoma of the parotid gland: a patient report.

Authors:  Motoki Nakabayashi; Kohei Shomori; Shuichi Kiya; Tatsushi Shiomi; Kanae Nosaka; Hisao Ito
Journal:  Yonago Acta Med       Date:  2010-09-01       Impact factor: 1.641

5.  Salivary gland neoplasms: an analysis of 74 cases.

Authors:  Deepika Sirohi; Rohit Sharma; Ramen Sinha; P Suresh Menon
Journal:  J Maxillofac Oral Surg       Date:  2009-08-11

6.  Carcinoma ex pleomorphic adenoma of the sublingual gland: a case report.

Authors:  Yasunori Ariyoshi; Masashi Shimahara; Toshiyuki Konda; Motomu Tsuji
Journal:  Int J Oral Sci       Date:  2012-01-12       Impact factor: 6.344

7.  Salivary gland tumors in maxillofacial region: a retrospective study of 130 cases in a southern Iranian population.

Authors:  Mahmoud Shishegar; Mohamad J Ashraf; Negar Azarpira; Bijan Khademi; Basir Hashemi; Amir Ashrafi
Journal:  Patholog Res Int       Date:  2011-07-03

8.  Basal cell adenoma of the upper lip from minor salivary gland origin.

Authors:  Eliana Maria Minicucci; Eloisa Bueno Pires de Campos; Silke Anna Thereza Weber; Maria Aparecida Custodio Domingues; Daniel Araki Ribeiro
Journal:  Eur J Dent       Date:  2008-07

9.  A review of 413 salivary gland tumours in the head and neck region.

Authors:  Ahmed O Lawal; Akinyele O Adisa; Bamidele Kolude; Bukola F Adeyemi; Mofoluwaso A Olajide
Journal:  J Clin Exp Dent       Date:  2013-12-01

10.  The Clinical Characteristics and CT Findings of Parotid and Submandibular Gland Tumours.

Authors:  Houdong Zuo
Journal:  J Oncol       Date:  2021-07-03       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.